期刊文献+

5,4'-二-正辛烷氧基-7-二氟亚甲基异黄酮对人乳腺癌细胞增殖和凋亡的影响 被引量:2

The inhibiting effect of 5,4-Di-n-octoxyl-7-gem-difluoromethylene-genistein on the growth of human breast cancer cells in vitro
下载PDF
导出
摘要 目的:探讨金雀异黄素(gen)衍生物5,4'-二-正辛烷氧基-7-二氟亚甲基异黄酮(5,4'-Di-n-octoxyl-7-gem-difluoromethylenegenisteinDOdFMG)体外选择性抑制人乳腺癌细胞增殖和诱导凋亡作用。方法:MTT法检测DOdFMG对MCF-7和HBL-100细胞生长的影响;流式细胞术和AO/EB荧光双染法测定DOdFMG诱导MCF-7细胞凋亡作用及对细胞周期的影响。结果:DOdFMG抑制MCF-7细胞生长,呈时间剂量依赖,比gen具有更强选择性和抗肿瘤活性;DOdFMG能诱导MCF-7细胞凋亡,DOdFMG40.0μM组比gen100μM组诱导凋亡的活性更强,DOdFMGMCF-7将MCF-7细胞阻滞于S期和G2期,呈浓度依赖。结论:DOdFMG能抑制人乳腺癌细胞系(MCF-7)细胞生长和诱导凋亡,是一种高效、毒副作用小的新型治疗乳腺癌候选药物。 Objective: To investigate the effect of the Genistein derivative 5,4'- Di - n - octoxyl - 7 - gem - difluoromethylene- genistein(DOdFMG) on the growth and apoptosis of human breast cancer( MCF- 7 ) cell line in vitro. Methods: MTT assay the influence of growth in MCF-7 cells and HBL- 100 cells was examinated; by MTY assay. The apoptosis of MCF - 7 cells was determined by AO/EB double fluorescence stain and PI staining flow cytometry and cell cycle was analyzed using flow cytometry. Results:DOdFMG significantly suppressed proliferation of MCF -7 cells in dose -dependant and time -dependant manner, having the obviously stronger antitumor activity and selectivity than GEN. The apoptosis of MCF -7cells induced and cell cycle was arrested at S stage and G2 stage by DOdFMG in a concentration dependent manner. Compared with GEN 1001μM set, the activity of inducing the apoptosis of DOddFMG 401μM set was stronger. Conclusion: DOddFMG can significantly inhibit MCF - 7 cells growth and induce their apoptosis. It is an efficiently new medicine to treat human breast cancer.
出处 《现代肿瘤医学》 CAS 2007年第4期482-484,共3页 Journal of Modern Oncology
关键词 乳腺癌 金雀异黄素 5 4’-二-正辛烷氧基-7-二氟亚甲基异黄酮 breast cancer genistein 5,4'- Di-n-octoxyl -7-gem - difluoromethylene- genistein
  • 相关文献

参考文献3

二级参考文献21

  • 1Ll Qi-Fu(Laboratory of Cell Biology, XiamenUniversity, Xiamen 361O05, Fuian Province, China).Effect of retinoic acid on the changes of nuclear matrix-intermediate filament system in gastric carcinoma cells[J].World Journal of Gastroenterology,1999,5(5):417-420. 被引量:17
  • 2Wi jsman JH,Jonker PR,Kei jzer R,et al.A new method to detect apoptosis in paraffin section in situ end labeling of fragmented DNA[J].J Histochem Cytochem,1993,41(1):7-11.
  • 3Pegram MD, Finn RS, Arzoo K, et al. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells[J]. Oncogene, 1997, 15(5): 537-5347.
  • 4Pegram M, Hsu S, Lewis G, et al. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers[J]. Oncogene, 1999, 18(13): 2241-2251.
  • 5Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-HEP2 antibody (Herceptina) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts[J]. Cancer Res, 1998, 58(13): 2825-2831.
  • 6Pietras RJ, Pegram MD, Finn RS, et al. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs[J]. Oncogene, 1998, 17(17): 2235-2249.
  • 7Petit AM, Rak J, Hung MC, et al. Neutralizing antibodies against epidermal growth factor and erbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors[J]. Am J Pathol, 1997, 151(6): 1523-1530.
  • 8Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized antip185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-over expressing metastatic breast cancer refractory to chemotherapy treatment[J]. J Clin Oncol, 1998, 16(8): 265926-265971.
  • 9Mass RD, Sanders C, Charlene K, et al. The concordance between the clinical trials assay (CTA) and fluorescence in situ hybridization (FISH) in the Herceptin pivotal trials[J]. Proc Am Soc Clin Oncol, 2000, 19: 75a.
  • 10Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease[J]. J Clin Oncol, 1999, 17(9): 2639-2648.

共引文献22

同被引文献22

  • 1宁映霞,曹建国,谢宛玉.5,4’-二-正辛烷氧基-7-二氟亚甲基异黄酮体外抗人卵巢癌作用研究[J].湖南师范大学学报(医学版),2007,4(1):36-40. 被引量:5
  • 2Jian-Guo CAO,Shu-Ping PENG,Li SUN,Hui LI,Li WANG,Han-Wu DENG.Vascular Basement Membrane-derived Multifunctional Peptide,a Novel Inhibitor of Angiogenesis and Tumor Growth[J].Acta Biochimica et Biophysica Sinica,2006,38(7):514-521. 被引量:15
  • 3宋祖军,王少波,王琦,张永和,尹文,刘健,郭亮.NF—κB的研究进展[J].世界急危重病医学杂志,2007,4(1):1693-1696. 被引量:27
  • 4阮杰,刘新光,梁念慈.蛋白激酶CK2在信号转导中的作用及其与肿瘤发生的关系[J].中国药理学通报,2007,23(5):574-577. 被引量:3
  • 5KROOM P A, CLIFFOOD M N, CROZIER A, et al. How Should We Assess the Effects of Exposure to Dietary Polyphenols in Vitro [J] .Am. J. Clim. Nutr. ,2004,80:15 - 20.
  • 6ORLANDINI M, SEMPLICI F, FERRUZZI R, et al. Protein Kinase CK2α' is Induced by Serum as a Delayed Early Gene and Cooperates with Ha-Ras in Fibroblast Transformation [ J ]. J. Biol. Chem., 1998,273 (33) : 2 192 - 2 197.
  • 7SELDIN D C, LANDESMAN-BOLLAG E, FARAGO M, et al. CK2 as a Pos-Itive Regulator of Wnt Signalling and Tumourigenesis [ J]. Mol. Cell. Biochem., 2005,274( 1 - 2) :63 - 67.
  • 8EDDY S F, GUO S, DEMICCO E G, et al. Inducible lkappaB ki-Nase/IkappaB Kinase Epsilon Expression is Induced by CK2 and Promotes Aberrant Nuclear Factor-KappaB Activation in Breast Cancer Cells [ J ]. Cancer Res., 2005,65 (24) :11 375 - 11 383.
  • 9MILLERBS illerBs, ZAND IE. Complete Reconstitution of Human Ikap-paB Kinase (IKK) Complex in Yeast. Assessment of Its Stoi- Chiometry and the Role of IKK Gamnaon the Complex Actirity in the Absense of Stimulation [J]. Jbiolchem,2001 ;276(39) :36 320 - 36 326.
  • 10SONG D H, DOMINGUEZ I, MIZUNO J, et al. CK2 Phosphorylation of the Armadillo Repeat Region of β-Catenin Potetiates Wnt Signaling [J] .J. Biol. Chem. ,2003;278(26) :24 018 - 24 025.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部